Location · Cincinnati, OH
Clinical trials in Cincinnati, OH
344 recruiting studies have a site in the Cincinnati area, and 80 of them accept healthy volunteers. The area includes Mason, West Chester, Fairfield, Blue Ash, Hamilton, Middletown and nearby cities.
344 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
More recruiting studies (pay not posted)
- RecruitingPhase 2/Phase 3
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
Takeda
- Location
- Birmingham, AL + 18 other US sites
- Eligibility basics
- Ages 16–70
- RecruitingPhase 2
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
Vanda Pharmaceuticals
- Location
- Tempe, AZ + 17 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
Direct Biologics, LLC
- Location
- Phoenix, AZ + 30 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries, Inc.
- Location
- Birmingham, AL + 53 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18
Amicus Therapeutics
- Location
- Gainesville, FL + 5 other US sites
- Eligibility basics
- Up to age 17
- Recruiting
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
Concept Medical Inc.
- Location
- Scottsdale, AZ + 24 other US sites
- Eligibility basics
- Ages 21+
- RecruitingPhase 4
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL
HealthTech Wound Care
- Location
- DeLand, FL + 9 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 4
Zopa Retreatment and Vector Shedding in Adults With RRP
Precigen, Inc
- Location
- Atlanta, GA + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Deciphera Pharmaceuticals, LLC
- Location
- Duarte, CA + 25 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam
Arsenal Medical, Inc.
- Location
- Birmingham, AL + 1 other US site
- Eligibility basics
- Ages 15+
- RecruitingPhase 1/Phase 2
A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
GC Biopharma Corp
- Location
- Los Angeles, CA + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Mezzion Pharma Co. Ltd
- Location
- Phoenix, AZ + 34 other US sites
- Eligibility basics
- Ages 12–18
- Recruiting
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
Endospan Ltd.
- Location
- Birmingham, AL + 23 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
Talphera, Inc
- Location
- Los Angeles, CA + 8 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Kartos Therapeutics, Inc.
- Location
- Birmingham, AL + 57 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
Impax Laboratories, LLC
- Location
- Little Rock, AR + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
- Location
- Mobile, AL + 101 other US sites
- Eligibility basics
- Ages 18–50 · Women only
- RecruitingPhase 2
Study of ALTO-300 in MDD
Alto Neuroscience
- Location
- Phoenix, AZ + 36 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 1/Phase 2
Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
Eledon Pharmaceuticals
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 18–100
- Recruiting
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
Kardion Inc
- Location
- Chandler, AZ + 16 other US sites
- Eligibility basics
- Ages 18–90
- Recruiting
A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing…
InspireMD
- Location
- Sacramento, CA + 7 other US sites
- Eligibility basics
- Ages 18–79
- Recruiting
Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
Innoventric LTD
- Location
- Thousand Oaks, CA + 8 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 1
Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy
Sardocor Corp.
- Location
- Kansas City, KS + 2 other US sites
- Eligibility basics
- Ages 18+ · Men only
- RecruitingPhase 4
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Upsher-Smith Laboratories
- Location
- La Jolla, CA + 5 other US sites
- Eligibility basics
- Ages 6–11